|
|
||||||||
The posttreatment performance of the Plasmodium falciparum histidine-rich protein rapid diagnostic test Determine Malaria pf (Abbott Laboratories, Tokyo, Japan) was assessed in 70 patients in central India with uncomplicated falciparum malaria who were treated with chloroquine, sulfadoxine-pyrimethamine, and arteether. Data were compared with those of microscopy. Results revealed that the sensitivity for predicting recrudescence by means of the Determine test after treatment with chloroquine on Day 14 was 75%, with 50% specificity. However, antigenemia was detected in 16% of patients as late as Day 21 in sulfadoxine-pyrimethamine-treated subjects with a drug-sensitive response. Clearance of parasitemia in thick blood smear and clearance of antigenemia appeared to parallel each other only in arteether-treated subjects. The observed diagnostic trends therefore mean that the potential of the Determine test to detect recrudescent infection is limited.
This article has been cited by other articles:
![]() |
H. HOPKINS, W. KAMBALE, M. R. KAMYA, S. G. STAEDKE, G. DORSEY, and P. J. ROSENTHAL COMPARISON OF HRP2- AND pLDH-BASED RAPID DIAGNOSTIC TESTS FOR MALARIA WITH LONGITUDINAL FOLLOW-UP IN KAMPALA, UGANDA Am J Trop Med Hyg, June 1, 2007; 76(6): 1092 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cheng and D. Bell Evidence Behind the WHO Guidelines: Hospital Care for Children: What is the Precision of Rapid Diagnostic Tests for Malaria? J Trop Pediatr, December 1, 2006; 52(6): 386 - 389. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |